Top Markets
#1 PulseChain PulseChain +43.68%
#2 Meteora Meteora +6.96%
#3 Bitway Bitway +6.91%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.67%
#5 eCash eCash +6.41%
#6 Casper Network Casper Network +6.15%
#7 Bitcoin SV Bitcoin SV +6.09%
#8 EthereumPoW EthereumPoW +5.72%
#9 Creditcoin Creditcoin +5.39%
#10 Fake World Assets Fake World Assets +5.30%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
IntelGenx Technologies Corp. IntelGenx Technologies Corp.

IntelGenx Technologies Corp.

IGX
Rank in Stocks #28345
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
Share Price
$0.17446996
Last synced: 2024-06-11
Market Cap
$26.97M
Change (1 day)
-0.57%
Change (1 year)
0.00%
Country
CA
Trade IntelGenx Technologies Corp. (IGX)

Category

Healthcare
Revenue for IntelGenx Technologies Corp. (IGX)
Revenue in Aug 2026 TTM: 0
According to IntelGenx Technologies Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for IntelGenx Technologies Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH